Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

被引:463
作者
Mantovani, Alessandro [1 ,2 ]
Byrne, Christopher D. [3 ,4 ]
Bonora, Enzo [1 ,2 ]
Targher, Giovanni [1 ,2 ]
机构
[1] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[2] Azienda Osped Univ Integrata Verona, Verona, Italy
[3] Univ Southampton, Fac Med, Nutr & Metab, Southampton, Hants, England
[4] Univ Hosp Southampton, Hlth Res Biomed Res Ctr, Southampton Natl Inst, Southampton, Hants, England
关键词
CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; FETUIN-A; ASSOCIATION; NAFLD; MELLITUS; IMPACT; COHORT;
D O I
10.2337/dc17-1902
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Several studies have explored the impact of nonalcoholic fatty liver disease (NAFLD) on risk of incident type 2 diabetes. However, the extent to which NAFLD may confer risk of incident diabetes remains uncertain. We performed a meta-analysis of relevant studies to quantify the magnitude of the association between NAFLD and risk of incident diabetes. RESEARCH DESIGN AND METHODS We collected data using PubMed, Scopus, and Web of Science from January 2000 to July 2017. We included only large (n >= 500) observational studies with a follow-up duration of at least 1 year in which NAFLD was diagnosed on imaging methods. Eligible studies were selected according to predefined keywords and clinical outcomes. Data from selected studies were extracted, and meta-analysis was performed using random-effects modeling. RESULTS A total of 19 observational studies with 296,439 individuals (30.1% with NAFLD) and nearly 16,000 cases of incident diabetes over amedian of 5 years were included in the final analysis. Patients with NAFLD had a greater risk of incident diabetes than those without NAFLD (random-effects hazard ratio [HR] 2.22, 95% CI 1.84-2.60; I-2 = 79.2%). Patients with more "severe" NAFLD were also more likely to develop incident diabetes; this risk increased across the ultrasonographic scores of steatosis (n = 3 studies), but it appeared to be even greater among NAFLD patients with advanced high NAFLD fibrosis score (n = 1 study; random-effects HR 4.74, 95% CI 3.54-5.94). Sensitivity analyses did not alter these findings. Funnel plot and Egger test did not reveal significant publication bias. Study limitations included high heterogeneity, varying degrees of confounder adjustment across individual studies, and lack of studies using liver biopsy. CONCLUSIONS NAFLD is significantly associated with a twofold increased risk of incident diabetes. However, the observational design of the eligible studies does not allow for proving causality.
引用
收藏
页码:372 / 382
页数:11
相关论文
共 53 条
[1]   Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases [J].
Adams, Leon A. ;
Anstee, Quentin M. ;
Tilg, Herbert ;
Targher, Giovanni .
GUT, 2017, 66 (06) :1138-1153
[2]   Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[3]   Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes A 4-year retrospective longitudinal study [J].
Bae, Ji Cheol ;
Rhee, Eun Jung ;
Lee, Won Young ;
Park, Se Eun ;
Park, Cheol Young ;
Oh, Ki Won ;
Park, Sung Woo ;
Kim, Sun Woo .
DIABETES CARE, 2011, 34 (03) :727-729
[4]   Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391
[5]   Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].
Ballestri, Stefano ;
Zona, Stefano ;
Targher, Giovanni ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Nascimbeni, Fabio ;
Roverato, Alberto ;
Guaraldi, Giovanni ;
Lonardo, Amedeo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944
[6]   The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans [J].
Benhamed, Fadila ;
Denechaud, Pierre-Damien ;
Lemoine, Maud ;
Robichon, Celine ;
Moldes, Marthe ;
Bertrand-Michel, Justine ;
Ratziu, Vlad ;
Serfaty, Lawrence ;
Housset, Chantal ;
Capeau, Jacqueline ;
Girard, Jean ;
Guillou, Herve ;
Postic, Catherine .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (06) :2176-2194
[7]   Histologic Scores for Fat and Fibrosis Associate With Development of Type 2 Diabetes in Patients With Nonalcoholic Fatty Liver Disease [J].
Bjorkstrom, Karl ;
Stal, Per ;
Hultcrantz, Rolf ;
Hagstrom, Hannes .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (09) :1461-1468
[8]   Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action [J].
Bril, Fernando ;
Cusi, Kenneth .
DIABETES CARE, 2017, 40 (03) :419-430
[9]   NAFLD: A multisystem disease [J].
Byrne, Christopher D. ;
Targher, Giovanni .
JOURNAL OF HEPATOLOGY, 2015, 62 :S47-S64
[10]   Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population [J].
Chang, Yoosoo ;
Jung, Hyun-Suk ;
Yun, Kyung Eun ;
Cho, Juhee ;
Cho, Yong Kyun ;
Ryu, Seungho .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (12) :1861-1868